
Vibostolimab
CAS No. 2231305-30-7
Vibostolimab ( —— )
产品货号. M34759 CAS No. 2231305-30-7
Vibostolimab 是一种 anti-TIGIT (T cell immunoglobulin and ITIM domain) 单克隆抗体。Vibostolimab 显示抗肿瘤活性,可用于非小细胞肺癌 (NSCLC) 和黑色素瘤的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥2946 | 有现货 |
![]() ![]() |
5MG | ¥4667 | 有现货 |
![]() ![]() |
10MG | ¥7494 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Vibostolimab
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Vibostolimab 是一种 anti-TIGIT (T cell immunoglobulin and ITIM domain) 单克隆抗体。Vibostolimab 显示抗肿瘤活性,可用于非小细胞肺癌 (NSCLC) 和黑色素瘤的研究。
-
产品描述Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research.
-
体外实验Vibostolimab binds to TIGIT and blocks the interaction between TIGIT and its ligands (CD112 and CD155), activating T lymphocytes which help to destroy tumor cells.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number2231305-30-7
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Niu J, et al. First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆. Ann Oncol. 2022 Feb;33(2):169-180.?
产品手册




关联产品
-
5-Amino-2-chloropyri...
5-氨基-2-氯吡啶是吡啶中间体。
-
MALAT1-IN-1
MALAT1-IN-1 以剂量依赖性方式调节 Malat1 下游基因,而不影响核富集丰富转录物 1 (Neat1) 的表达。
-
1-(3,4-dimethoxyphen...
1-(3,4-Dimethoxyphenyl)-2-(4-allly-2,6-dimethoxyphenoxy)propan-1-ol shows anti-staphylococcal activity against a total of five multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus strains and the minimum inhibitory concentrations (MICs) are in the range of 128-256 ug/ml.